IP Library Granted Patent US 10,323,078
Granted Patent B2
US 10,323,078 · App. 15/559,984 · Granted Jun 18, 2019

Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases

Inventors: Nicolas Dupin (Colombes, FR); Philippe Grange (Chennevieres, FR); Vincent Calvez (Paris, FR); Joël Raingeaud (Palaiseau, FR)
Assignees: Universite Paris Descartes; Assistance Publique—Hopitaux De Paris; Universite Paris—Sud; Universite Pierre et Marie Curie (Paris 6); Institut National De La Sante et De La Recherche Medicale (INSERM); Centre National De La Recherche Scientifique (CNRS); Institut Gustave-Roussy
C07K14/75A61K9/0014A61K9/0019A61P17/06A61P17/10A61P29/00C12N7/00A61K38/00C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,323,078
App. No.
15/559,984
Granted
Jun 18, 2019
Kind
B2
Abstract

A present invention relates to isolated peptides obtained from human fibrinogen for their use as drug, particularly for the prevention and/or the treatment of inflammatory skin diseases, more particularly acne. The present invention also relates to fragments of these polypeptides, nucleic acid molecules encoding them, expression vectors, host cells, a pharmaceutical composition and a combination product containing them, and their use for treating and/or preventing inflammatory skin diseases, particularly acne.

Claims (6)

1. A method for treating and/or preventing a skin inflammatory disease comprising administering to a subject in need thereof an isolated polypeptide comprising an amino acid sequence with at least 80% identity with SEQ ID NO:1 after optimal global alignment or a fragment thereof comprising an amino acid sequence with at least 80% identity with any one of SEQ ID NOs:2, 5, 7, 8, 9, 10, 11, 12, 13, and 47 after optimal global alignment.

2. The method according to claim 1 , wherein said polypeptide is selected from SEQ ID NOs:2, 5, 7, 8, 9, 10, 11, 12, 13, and 47 or a polypeptide with at least 80% identity with one of SEQ ID NOs: 2, 5, 7, 8, 9, 10, 11, 12, 13, and 47 after optimal global alignment.

3. The method according to claim 1 , wherein the skin inflammatory diseases is acne.

4. The method according to claim 1 , wherein said isolated polypeptide or fragment thereof inhibits the interaction with fibrinogen of at least one microbial protein involved in bacterial adhesion to a host cell.

5. The method according to claim 1 , wherein the skin inflammatory disease is psoriasis.

6. The method according to claim 1 , wherein said isolated polypeptide or fragment thereof inhibits the interaction with fibrinogen of at least one microbial protein involved in bacterial adhesion to a host cell, wherein the bacteria is P. acnes , and wherein the fibrinogen is human fibrinogen.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 058630 FRAME: 0874. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded May 4, 2022
From: UNIVERSITÉ PARIS-SUD
To: UNIVERSITÉ PARIS-SACLAY
Reel/Frame 059952/0787 →
CHANGE OF NAME Recorded Mar 25, 2022
From: UNIVERSITÉ DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059504/0225 →
MERGER Recorded Jan 18, 2022
From: UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6)
To: SORBONNE UNIVERSITÉ
Reel/Frame 058680/0234 →
MERGER Recorded Jan 12, 2022
From: UNIVERSITÉ PARIS-SUD
To: UNIVERSITÉ PARIS-SACLAY
Reel/Frame 058630/0874 →
MERGER Recorded Jul 22, 2021
From: UNIVERSITE DE PARIS DESCARTES
To: UNIVERSITE DE PARIS
Reel/Frame 056958/0603 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2018
From: DUPIN, NICOLAS; GRANGE, PHILIPPE; CALVEZ, VINCENT; RAINGEAUD, JOEL
To: UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS; UNIVERSITE PARIS-SUD; UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT GUSTAVE-ROUSSY
Reel/Frame 045421/0409 →
Priority Claims (1)
EP 15305414 · Mar 20, 2015 · regional
Continuity (1)
Related Publication 20180105574A1 · Apr 19, 2018
Cited By (1)
US 12,502,424